Mechanisms of drug-induced driving impairment: A dimensional approach

Human Psychopharmacology

Volumn 13, Issue SUPPL. 2, 1998, Pages

  Riedel, W J ^a,b   Vermeeren, A ^b   Van Boxtel, M P J ^b   Vuurman, E F P M ^b   Verhey, F R J ^b   Jolles, J ^b   Ramaekers, J G ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Arousal; Driving performance; Impairment; Neurotransmission; Psychoactive drugs

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DOPAMINE; HISTAMINE; NORADRENALIN; PSYCHOTROPIC AGENT; SEROTONIN;

AROUSAL; ATTENTION; BEHAVIOR; CHOLINERGIC TRANSMISSION; COORDINATION; DOPAMINERGIC TRANSMISSION; DRIVING ABILITY; ENERGY; ERROR; HUMAN; INFORMATION PROCESSING; NEUROCHEMISTRY; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SEDATION; TRAFFIC;

EID: 0031731847     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(1998110)13:2+3.0.CO;2-1     Document Type: Review

References (101)

1. Bartus, R. T., Dean, R. L., Beer, B. and Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-417.
2. Blokland, A. (1996). Acetylcholine: a neurotransmitter for learning and memory? Brain Research Reviews, 21, 285-300.
3. Brandeis, D., Naylor, H., Halliday, R., Callaway, E. and Yano, L. (1992). Scopolamine effects on visual information processing, attention, and event-related potential map latencies. Psychophysiology, 29, 315-336.
4. Brookhuis, K. A., De Vries, G. and De Waard, D. (1993). Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance. British Journal of Clinical Pharmacology, 36, 67-70.
5. Brookhuis, K., Volkerts, E. and O'Hanlon, J. F. (1987). The effects of anxiolytics on aspects of driving performance and driving related skills; a study with anxious patients and healthy volunteers. Drugs & Driving II, Maastricht.
6. Brookhuis, K. A., Volkerts, E. R. and O'Hanlon, J. F. (1990). Repeated dose effects of lormetazepam and flurazepam upon driving performance. European Journal of Clinical Pharmacology, 39, 83-87.
7. Callaway, E. (1983). The pharmacology of human information processing. Psychophysiol, 20, 359-371.
8. Callaway, E., Halliday, R., Naylor, H., Yano, L. and Herzig, K. (1994). Drugs and human information processing. Neuropsychopharmacology, 10, 9-19.
9. Clayton, C. J. and Hicks, R. E. (1994). Ethanol, monoamines, and affect. J Neural Transm Gen Sect, 98, 169-195.
10. Coper, H. and Herrmann, W. M. (1988). Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functions. Pharmacopsychiatry, 21, 211-217.
11. Coull, J. T. (1994). Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging, 5, 116-126.
12. Cowen, P. J., Power, A. C., Ware, C. J. and Anderson, I. M. (1994). 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. British Journal of Psychiatry, 164, 372-379.
13. Davis, J. M. and Bailey, S. P. (1997). Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc, 29, 45-57.
14. DiChiara, G., Acquas, E. and Tanda, G. (1996). Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link. Alcohol, 13, 13-17.
15. Duka, T., Ott, H., Rohloff, A. and Voet, B. (1996). The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills. Psychopharmacology Berl, 123, 361-373.
16. Dunne, M. P. and Hartley, L. R. (1986). Scopolamine and the control of attention in humans. Psychopharmacology, 89, 94-97.
17. Everitt, B. J. and Robbins, T. W. (1997). Central cholinergic systems and cognition. Annual Review Of Psychology, 48, 649-684.
18. Frowein, H. W. and Sanders, A. F. (1978). Effects of amphetamine and barbiturate in a serial reaction task under paced and self-paced conditions. Acta Psychologica, 42, 263-276.
19. Geyer, M. A. (1995). Serotonergic functions in arousal and motor activity. Behavioural Brain Research, 73, 31-35.
20. Halliday, R., Callaway, E. and Lannon, R. (1989). The effects of clonidine and yohimbine on human information processing. Psychopharmacology, 99, 563-566.
21. Hasbroucq, T., Rihet, P., Blin, O. and Possamai, C. A. (1997). Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neuroscience Letters, 229, 204-208.
22. Hindmarch, I., Alford, C., Barwell, F. and Kerr, J. S. (1992). Measuring the side effects of psychotropics: The behavioural toxicity of antidepressants. Journal of Psychopharmacology, 6, 198-203.
23. Jacobs, B.L. and Fornal, C. A. (1995). Serotonin and behavior. A general hypothesis. In Psychopharmacology: The Fourth Generation of Progress, Bloom F. E. and Kupfer, D. J. (Eds), Raven Press, New York, pp. 461-469.
24. Koelega, H. S. (1989). Benzodiazepines and vigilance performance; a review. Psychopharmacology, 98, 145-156.
25. Koelega, H. S. (1993). Stimulant drugs and vigilance performance: A review. Psychopharmacology, 111, 1-16.
26. Koob, G. F. (1996). Hedonic valence, dopamine and motivation. Mol Psychiatry, 1, 186-189.
27. Koob, G. F., Le Moal, M. (1997). Drug abuse: hedonic homeostatic dysregulation. Science, 278, 52-58.
28. Kopelman, M. D. (1986). The cholinergic neurotransmitter system in human memory and dementia: a review. Special Issue: Human memory. Quarterly Journal of Experimental Psychology Human Experimental Psychology, 38, 535-573.
29. Leonard, B. E. (1997). Fundamentals of Psychopharmacology, 2nd edn. John Wiley and Sons, Chichester.
30. Lin, J.-S., Hou, Y., Sakai, K. and Jouvet, M. (1996). Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. The Journal of Neuroscience, 16, 1523-1537.
31. Linnoila, M., Guthrie, S. and Lister, R. (1986). Mechanisms of drug-induced impairment of driving. In Drugs & Driving, O'Hanlon, J. F. and Gier, J. Jd (Eds), Taylor & Francis, London, pp. 29-49.
32. Logan, B. K. (1996). Methamphetamine and driving impairment. Journal of Forensic Sciences, 41, 457-464.
33. Logan, B. K., Schwilke, E. W. (1996). Drug and alcohol use in fatally injured drivers in Washington State. Journal of Forensic Sciences, 41, 505-510.
34. Louwerens, J. W., Brookhuis, K. A. and O'Hanlon, J. F. (1986). Several antidepressants' acute effects upon actual driving performance and subjective mental activation. In Drugs & Driving, O'Hanlon, J. F. and Gier, J. Jd (Eds), Taylor & Francis, London, pp. 203-212.
35. Maes, M. and Meltzer, H. Y. (1995). The serotonin hypothesis of major depression. In Psychopharmacology: The Fourth Generation of Progress, Bloom, F. E. and Kupfer, D. J. (eds), Raven Press, New York, pp. 933-944.
36. Malizia, A. L. and Nutt, D. J. (1995). Psychopharmacology of benzodiazepines - an update. Human Psychopharmacology, 10, S1-S14.
37. Meck, W. H. (1996). Neuropharmacology of timing and time perception. Cognitive Brain Research, 3, 227-242.
38. Michon, J. A. (1989). Explanatory pitfalls and rule-based driver models. Accident Analysis and Prevention, 21, 341-353.
39. Mizuki, Y., Suetsugi, M., Ushijima, I. and Yamada, M. (1996). Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety. Progress in Neuro Psychopharmacology and Biological Psychiatry, 20, 1353-1367.
40. O'Hanlon, J. F. (1984). Driving performance under the influence of drugs: rationale for, and application of, a new test. British Journal of Clinical Pharmacology, 18, 121S-129S.
41. O'Hanlon, J. F. (1991). Review of buspirone's effects on human performance and related variables. European Neuropsychopharmacology, 1, 489-501.
42. O'Hanlon, J. F., Haak, T. W., Blaauw, G. J. and Riemersma, J. B. (1982). Diazepam impairs lateral position control in highway driving. Science, 217, 79-81.
43. O'Hanlon, J. F. and Ramaekers, J. G. (1995). Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-1994. Allergy: European Journal of Allergy and Clinical Immunology, 50, 234-242.
44. O'Hanlon, J. F., Robbe, H. W. J., Vermeeren, A., van Leeuwen, C. and Danjou, P. (1998). Venlafaxine's effects on healthy volunteer's driving, psychomotor and vigilance performance during a 15-day fixed (75 mg/d) and incremental (75-150 mg/d) dosing regimens. Journal of Clinical Psychopharmacology, in press.
45. O'Hanlon, J. F. and Vermeeren, A. (1988). Effects of Ro 15-1788 on the vigilance performance of sleep-deprived men. Human Psychopharmacology, 3, 267-274.
46. O'Hanlon, J. F., Vermeeren, A., Uiterwijk, M. M. C., Van Veggel, L. M. A. and Swijgman, H. F. (1995). Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies. Neuropsychobiology, 31, 81-88.
47. O'Hanlon, J. F. and Volkerts, E. R. (1986). Hypnotics and actual driving performance. Acta Psychiatr Scand, 74, S95-S104.
48. O'Hanlon, J. F., Volkerts, E. R., Vries, Gd., Arkel, Av., Wiethoff, M. and Meijer, T. (1983). Flurazepam HCl's residual ('hangover') effects upon actual driving performance I. VSC.
49. Oxman, T. E. (1996). Antidepressants and cognitive impairment in the elderly. Journal of Clinical Psychiatry, 5, 38-44.
50. Preston, G. C., Ward, C., Lines, C. R., Poppleton, P., Haigh, J. R. and Traub, M. (1989). Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. Psychopharmacology, 98, 487-494.
51. Pribram, K. H. and McGuinness, D. (1975). Arousal, activation, and effort in the control of attention. Psychological Review, 82, 116-149.
52. Ramaekers, J. G., Muntjewerff, N. D. and O'Hanlon, J. F. (1995). A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. British Journal of Clinical Pharmacology, 39, 397-404.
53. Ramaekers, J. G., Muntjewerff, N. D., Van Veggel, L. M. A., Uiterwijk, M. M. C. and O'Hanlon, J. F. (1998). Effects of ascending, nocturnal doses of mirtazapine and mianserin on daytime psychomotor and driving performance, and sleep in young, healthy volunteers. Human Psychopharmacology, ??. ??-??.
54. Ramaekers, J. G. and O'Hanlon, J. F. (1994). Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. European Journal of Clinical Pharmacology, 47, 261-266.
55. Ramaekers, J. G., Swijgman, H. F. and O'Hanlon, J. F. (1992a). Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology Berl Suppl, 106, S62-S67.
56. Ramaekers, J. G., Uiterwijk, M. M. and O'Hanlon, J. F. (1992b). Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. European Journal of Clinical Pharmacology, 42, 363-369.
57. Ramaekers, J. G., van Veggel, L. M. A. and O'Hanlon, J. F. (1994). A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep. XVIIIth C.I.N.P. Congress (1992, Nice, France). Clinical Neuropharmacology, 17, S9-S18.
58. Rammsayer, T. H. (1997), Effects of body core temperature and brain dopamine activity on timing processes in humans. Biological Psychology, 46, 169-192.
59. Reid, J. L., Panfilov, V., MacPhee, G. and Elliott, H. L. (1995). Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol. Ann N Y Acad Sci, 763, 673-678.
60. Reilly, J. G., McTavish, S. F. B. and Young, A. H. (1997). Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. Journal Of Psychopharmacology, 11, 381-392.
61. Riedel, W. J., Hogervorst, E., Verhey, F. R. J. and Jolles, J. (1997). Measuring cognitive abilities in cholinergic dysfunction. In Human Psychopharmacology: Measures and Methods; Vol. VI, Hindmarch, I. and Stonier, P. D. (eds), Wiley, Chichester, pp. 29-56.
62. Riedel, W. J., Klaassen, T., Deutz, N. E. P., Honig, A., Van Someren, A. and Van Praag, H. M. (1998). Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology, in press.
63. Riedel, W. J., Quasten, R. and O'Hanlon, J. F. (1988). Effects of midazolam triazolam and temazepam on shiftworkers' day-sleep and subsequent driving performance. Psychopharmacology, 96, 156S.
64. Riedel, W. J., Ramaekers, J. G., Uiterwijk, M. and O'Hanlon, J. F. (1990). Higher doses of terfenadine and loratadine acute and subchronic effects on psychomotor and actual driving performance. Institute for Drugs Safety and Behavior, University of Limburg.
65. Riedel, W. J., Schoenmakers, E. A. J. M. and O'Hanlon, J. F. (1989). Sedation and performance impairment with antihistamines. In Management of Allergy in the 1990's, Kaliner, M. (Ed.), Hans Huber, Toronto, pp. 38-49.
66. Riedel, W. J. and Van Praag, H. M. (1995). Avoiding and managing anticholinergic effects of and depressants. CNS Drugs, 3, 245-259.
67. Rimmer, S. J. and Church, M. K. (1990). The pharmacology and mechanisms of action of histamine H1-antagonists. Clin Exp Allergy, 2, 3-17.
68. Robbe, H. W. J. and O'Hanlon, J. F. (1990). Effects of acrivastine acrivastine plus pseudoephedrine and triprolidine on highway driving. Institute for Drugs Safety and Behavior, University of Limburg.
69. Robbe, H. W. J. and O'Hanlon, J. F. (1995). Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. European Neuropsychopharmacology, 5, 35-42.
70. Robbins, T. and Everitt, B. (1995). Arousal systems and attention. In The Cognitive Neurosciences, Gazzaniga, M. (Ed.), MIT Press, Cambridge MA, pp. 703-720.
71. Robbins, T. and Everitt, B. (1996). Neurobehavioural mechanisms of reward and motivation. Current Opinion in Neurobiology, 6, 228-236.
72. Robbins, T. W. (1997). Arousal systems and attentional processes. Biological Psychology, 45, 57-71.
73. Rowley, B., Van, F., Mortimore, C. and Connell, J. (1997). Effects of acute tryptophan depletion on tests of frontal and temporal lobe function. Journal of Psychopharmacology, 11, A60.
74. Rusted, J. (1994). Cholinergic blockade and human information processing: are we asking the right questions? Journal of Psychopharmacology, 8, 54-59.
75. Sanders, A. F. (1983). Towards a model of stress and human performance. Acta Psychologica, 53, 61-97.
76. Sanders, A. F. (1986). Drugs, driving and the measurement of human performance. In Drugs & Driving, O'Hanlon, J. F. and Gier, J. Jd (Eds), Taylor & Francis, London, pp. 3-16.
77. Schmitt, J. A. J., Jorissen, B., Sobczak, S., Van Boxtel, M. P. J., Deutz, N. E. P. and Riedel, W. J. (submitted). Tryptophan depletion impairs memory consolidation, but improves focused attention.
78. Schoenmakers, E. A. J. M., Robbe, H. W. J. and O'Hanlon, J. F. (1988). Acute and subchronic effects of the antidepressants levoprotiline and doxepin. Psychopharmacology, 96, 232S.
79. Schwartz, J.-C., Arrang, J.-M., Garbarg, M. and Traiffort, E. (1995). Histamine. In Psychopharmacology: The Fourth Generation of Progress, Bloom, F. E. and Kupfer, D. J. (eds), Raven Press, New York, pp. 397-405.
80. Snyder, S. H. (1996). Drugs and the brain. Scientific American Library, New York.
81. Thut, G., Schultz, W., Roelcke, U., Nienhusmeier, M., Missimer, J., Maguire, R., P. and Leenders, K. L. (1997). Activation of the human brain by monetary reward. Neuroreport, 8, 1225-1228.
82. Unema, P. (1995). Eye Movements and Mental Effort. Technical University, Berlin.
83. Van Laar, M. W., Van Willigenburg, A. P. P. and Volkerts, E. R. (1995). Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. Journal of Clinical Psychopharmacology, 15, 30-40.
84. Van Laar, M. W., Volkerts, E. R. and Van Willigenburg, A. P. (1992). Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. Journal of Clinical Psychopharmacology, 12, 86-95.
85. Van Praag, H. M. (1989). Moving ahead yet falling behind. A critical appraisal of some trends in contemporary depression research. Neuropsychobiology, 22, 181-193.
86. Van Praag, H. M. (1996). Serotonin related, anxiety/ aggression driven, Stressor precipitated depression: a psycho biological hypothesis. European Psychiatry, 11, 57-67.
87. Vermeeren, A., Danjou, P. E. and O'Hanlon, J. F. (1998a). Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Human Psychopharmacology, 13, S98-S107.
88. Vermeeren, A. and O'Hanlon, J. F. (1998). Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. Journal of Allergy and Clinical Immunology, 101, 306-311.
89. Vermeeren, A., O'Hanlon, J. F., Declerck, A. C. and Kho, L. (1995). Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Therapeutica, 21, 47-64.
90. Vermeeren, A., Ramaekers, J. G. and O'Hanlon, J. F. (1998b). Residual effects of chlorpheniramine and flurazepam on driving performance. Human Psychopharmacology, ??, ??-??.
91. Volkerts, E. R., Abbink, F., Laar, M. Wv., Plomp, T. A. and Maes, R. A. A. (1988). Comparison of the effects of ritanserin 5 mg bid and lorazepam 1·5 mg bid upon driving performance in an over-the-road driving test. NIDDR.
92. Volkerts, E. R., Brookhuis, K. A. and O'Hanlon, J. F. (1987). The effects of treatment with buspirone, diazepam and lorazepam on driving performance in real traffic. In Alcohol, Drugs and Traffic Safety-T86, Noordzij, P. C. and Roszbach, R. (Eds). Elsevier, Amsterdam, pp. 217-221.
93. Volkerts, E. R., Louwerens, J. W., Gloerich, A. B. M., Brookhuis, K. A. and O'Hanlon, J. F. (1984a). Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. VSC.
94. Volkerts, E. R., Van Laar, M. W., Van Willigenburg, A. P. and Plomp, T. A. (1992a). A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg. Human Psychopharmacology, 7, 297-309.
95. Volkerts, E, R., Van Willigenburg, A. P., Van Laar, M. W. and Maes, R. A. (1992b). Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness. Human Psychopharmacology, 7, 227-238.
96. Volkerts, E. R., Vries, Gd., Meijer, T. and O'Hanlon, J. F. (1984b). Driving performance the day after use of loprazolam, flunitrazepam and placebo. VSC.
97. Vuurman, E., Uiterwijk, M., Rosenzweig, P. and O'Hanlon, J. F. (1994). Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. European Journal of Clinical Pharmacology, 47, 253-259.
98. Warburton, D. M. and Wesnes, K. (1984). Drugs as research tools in psychology: Cholinergic drugs and information processing. Neuropsychobiology, 11, 121-132.
99. Weinstein, A., Wilson, S., Bailey, J. and Nutt, D. (1996). Sedative antidepressants impair visual detection mechanisms in humans. Journal Of Psychopharmacology, 10, 141-145.
100. Wetherell, A. (1986). Effects of atropine on drivers' perceptual-motor and decisionmaking behavior. In Drugs & Driving, O'Hanlon, J. F. and De Gier, J. J. (Eds), Taylor & Francis, London, pp. 291-302.
101. Ziegler, G., Ludwig, L. and Fritz, G. (1986). Effect of the specific benzodiazepine antagonist Ro 15-1788 on sleep. Pharmacopsychiatry, 19, 200-201.